Hepatitis C: transmission, treatment and occupational risk.
There is a risk to nurses of contracting hepatitis C through occupational exposure, although in the UK infection is mainly limited to intravenous drug users. In this article Peter Washer discusses what is currently known about the virus, mainly focusing on transmission, treatment and the risk of occupational exposure.
Washer
P
P
Faculty of Health, South Bank University, London. washerpj@sbu.ac.uk
D000359:Aftercare / Q000379:methods; D000998:Antiviral Agents / Q000627:therapeutic use; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy* / Q000635:transmission*; D006801:Humans; D017053:Infection Control; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control* / Q000706:statistics & numerical data; D016898:Interferon-alpha / Q000627:therapeutic use; D009740:Nursing Staff; D009784:Occupational Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D016273:Occupational Exposure / Q000009:adverse effects*; D012254:Ribavirin / Q000627:therapeutic use; D012307:Risk Factors; D006113:United Kingdom / Q000453:epidemiology
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin